Condition category
Cancer
Date applied
28/02/2001
Date assigned
28/02/2001
Last edited
18/08/2009
Prospective/Retrospective
Retrospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Not provided at time of registration

Trial website

Contact information

Type

Scientific

Primary contact

Miss Sharon Naylor

ORCID ID

Contact details

MRC Clinical Trials Unit
222 Euston Road
London
NW1 2DA
United Kingdom

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

TE10

Study information

Scientific title

Acronym

Study hypothesis

To define the optimum field size for administration of radiotherapy

Ethics approval

Not provided at time of registration.

Study design

Randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Hospitals

Trial type

Treatment

Patient information sheet

Condition

Cancer

Intervention

Two arms both receive 30 Gy in 15 fractions radiotherapy.
Arm 1: Para-aortic strip field
Arm 2: Dog led field

Intervention type

Other

Phase

Not Specified

Drug names

Primary outcome measures

Pelvic recurrence rate

Secondary outcome measures

Not provided at time of registration

Overall trial start date

01/03/1989

Overall trial end date

31/12/1993

Reason abandoned

Eligibility

Participant inclusion criteria

Stage I disease, histologically confirmed seminomatous germ cell tumour

Participant type

Patient

Age group

Not Specified

Gender

Male

Target number of participants

478

Participant exclusion criteria

Patients with previous ipsilateral inguinal operations.

Recruitment start date

01/03/1989

Recruitment end date

31/12/1993

Locations

Countries of recruitment

United Kingdom

Trial participating centre

MRC Clinical Trials Unit
London
NW1 2DA
United Kingdom

Sponsor information

Organisation

Medical Research Council (MRC) (UK)

Sponsor details

20 Park Crescent
London
W1B 1AL
United Kingdom
+44 20 7636 5422
clinical.trial@headoffice.mrc.ac.uk

Sponsor type

Research council

Website

http://www.mrc.ac.uk

Funders

Funder type

Research council

Funder name

Medical Research Council (MRC) (UK)

Alternative name(s)

MRC

Funding Body Type

private sector organisation

Funding Body Subtype

other non-profit

Location

United Kingdom

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

1999 results in http://www.ncbi.nlm.nih.gov/pubmed/10561173

Publication citations

  1. Results

    Fosså SD, Horwich A, Russell JM, Roberts JT, Cullen MH, Hodson NJ, Jones WG, Yosef H, Duchesne GM, Owen JR, Grosch EJ, Chetiyawardana AD, Reed NS, Widmer B, Stenning SP, Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial. Medical Research Council Testicular Tumor Working Group., J. Clin. Oncol., 1999, 17, 4, 1146.

Additional files

Editorial Notes